Clinical Trial Update: Ramelteon in the Prevention of Post-operative Delirium [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ramelteon for prevention of post-operative delirium has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amnestic Disorders
• Cognitive Disorders
• Delirium
• Dementia

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Johns Hopkins University | Conditions: Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders | Phase 2 | Status: COMPLETED | Results posted: 2020-06-30